Mesenchymal stem cell therapy (MSCT) for immune and inflammatory diseases continues to
be popular based on progressive accumulation of preclinical mechanistic evidence. This …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
characterized by demyelination and axonal degeneration. MS patients typically present with …

Background Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central
nervous system (CNS). MS affects millions of people and causes a great economic and …

Abstract The T-helper 17 (Th17) cell and regulatory T cell (Treg) axis plays a crucial role in
the development of multiple sclerosis (MS), which is regarded as an immune imbalance …

Multiple sclerosis is a chronic autoimmune disease of the central nervous system and is
generally considered to be a non-traumatic, physically debilitating neurological disorder. In …

Currently, there is still no cure for multiple sclerosis (MS), which is an autoimmune and
neurodegenerative disease of the central nervous system. Treatment options predominantly …

Regenerative medicine, encompassing various therapeutic approaches aimed at tissue
repair and regeneration, has emerged as a promising field in the realm of physical therapy …

Neurological disorders include a wide spectrum of clinical conditions affecting the central
and peripheral nervous systems. For these conditions, which affect hundreds of millions of …

Multiple sclerosis (MS) is a chronic neuro-inflammatory disease resulting in disabilities that
negatively impact patients' life quality. While current treatment options do not reverse the …

Multiple sclerosis (MS) is a chronic neurodegenerative, inflammatory, and demyelinating
disease of the central nervous system (CNS). Current medicines are not sufficient to control …